Cargando…

Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis

BACKGROUND: Sepsis is a dysregulated host response to infection and a major cause of death worldwide. Respiratory tract infections account for most sepsis cases and depending on the place of acquisition, i.e., community or hospital acquired infection, differ in etiology, antimicrobial resistance and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Narendra Kumar, Ferreira, Bianca Lima, Tashima, Alexandre Keiji, Brunialti, Milena Karina Colo, Torquato, Ricardo Jose Soares, Bafi, Antonio, Assuncao, Murillo, Azevedo, Luciano Cesar Pontes, Salomao, Reinaldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631513/
https://www.ncbi.nlm.nih.gov/pubmed/31341447
http://dx.doi.org/10.1186/s12014-019-9252-2
_version_ 1783435534646902784
author Sharma, Narendra Kumar
Ferreira, Bianca Lima
Tashima, Alexandre Keiji
Brunialti, Milena Karina Colo
Torquato, Ricardo Jose Soares
Bafi, Antonio
Assuncao, Murillo
Azevedo, Luciano Cesar Pontes
Salomao, Reinaldo
author_facet Sharma, Narendra Kumar
Ferreira, Bianca Lima
Tashima, Alexandre Keiji
Brunialti, Milena Karina Colo
Torquato, Ricardo Jose Soares
Bafi, Antonio
Assuncao, Murillo
Azevedo, Luciano Cesar Pontes
Salomao, Reinaldo
author_sort Sharma, Narendra Kumar
collection PubMed
description BACKGROUND: Sepsis is a dysregulated host response to infection and a major cause of death worldwide. Respiratory tract infections account for most sepsis cases and depending on the place of acquisition, i.e., community or hospital acquired infection, differ in etiology, antimicrobial resistance and outcomes. Accordingly, the host response may be different in septic patients secondary to community-acquired pneumonia and hospital acquired pneumonia (HAP). Proteomic analysis is a useful approach to evaluate broad alterations in biological pathways that take place during sepsis. Here we evaluated plasma proteome changes in sepsis secondary to HAP. METHODS: Plasma samples were obtained from patients (n = 27) at admission and after 7 days of follow-up, and were analyzed according to the patients’ outcomes. The patients’ proteome profiles were compared with healthy volunteers (n = 23). Pooled plasma samples were labeled with isobaric tag for relative and absolute quantitationand analyzed by LC–MS/MS. We used bioinformatics tools to find altered functions and pathways. Results were validated using biochemical estimations and ELISA tests. RESULTS: We identified 159 altered proteins in septic patients; most of them were common when comparing patients’ outcomes, both at admission and after 7 days. The top altered biological processes were acute inflammatory response, response to wounding, blood coagulation and homeostasis. Lipid metabolism emerged as the main altered function in patients, with HDL as a central node in the network analysis, interacting with downregulated proteins, such as APOA4, APOB, APOC1, APOL1, SAA4 and PON1. Validation tests showed reduced plasma levels of total cholesterol, HDL-C, LDL-C, non-HDL cholesterol, apolipoproteins ApoA1 and ApoB100, and Paraoxonase 1 in HAP patients. CONCLUSION: Proteomic analysis pointed to impairment of lipid metabolism as a major change in septic patients secondary to HAP, which was further validated by the reduced levels of cholesterol moieties and apolipoproteins in plasma. Our results stress the involvement of lipids in the pathogenesis of sepsis, which is in accordance with previous reports supporting the role of lipid moieties in pathogen toxin clearance and in modulating inflammatory responses. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12014-019-9252-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6631513
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66315132019-07-24 Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis Sharma, Narendra Kumar Ferreira, Bianca Lima Tashima, Alexandre Keiji Brunialti, Milena Karina Colo Torquato, Ricardo Jose Soares Bafi, Antonio Assuncao, Murillo Azevedo, Luciano Cesar Pontes Salomao, Reinaldo Clin Proteomics Research BACKGROUND: Sepsis is a dysregulated host response to infection and a major cause of death worldwide. Respiratory tract infections account for most sepsis cases and depending on the place of acquisition, i.e., community or hospital acquired infection, differ in etiology, antimicrobial resistance and outcomes. Accordingly, the host response may be different in septic patients secondary to community-acquired pneumonia and hospital acquired pneumonia (HAP). Proteomic analysis is a useful approach to evaluate broad alterations in biological pathways that take place during sepsis. Here we evaluated plasma proteome changes in sepsis secondary to HAP. METHODS: Plasma samples were obtained from patients (n = 27) at admission and after 7 days of follow-up, and were analyzed according to the patients’ outcomes. The patients’ proteome profiles were compared with healthy volunteers (n = 23). Pooled plasma samples were labeled with isobaric tag for relative and absolute quantitationand analyzed by LC–MS/MS. We used bioinformatics tools to find altered functions and pathways. Results were validated using biochemical estimations and ELISA tests. RESULTS: We identified 159 altered proteins in septic patients; most of them were common when comparing patients’ outcomes, both at admission and after 7 days. The top altered biological processes were acute inflammatory response, response to wounding, blood coagulation and homeostasis. Lipid metabolism emerged as the main altered function in patients, with HDL as a central node in the network analysis, interacting with downregulated proteins, such as APOA4, APOB, APOC1, APOL1, SAA4 and PON1. Validation tests showed reduced plasma levels of total cholesterol, HDL-C, LDL-C, non-HDL cholesterol, apolipoproteins ApoA1 and ApoB100, and Paraoxonase 1 in HAP patients. CONCLUSION: Proteomic analysis pointed to impairment of lipid metabolism as a major change in septic patients secondary to HAP, which was further validated by the reduced levels of cholesterol moieties and apolipoproteins in plasma. Our results stress the involvement of lipids in the pathogenesis of sepsis, which is in accordance with previous reports supporting the role of lipid moieties in pathogen toxin clearance and in modulating inflammatory responses. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12014-019-9252-2) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-16 /pmc/articles/PMC6631513/ /pubmed/31341447 http://dx.doi.org/10.1186/s12014-019-9252-2 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Sharma, Narendra Kumar
Ferreira, Bianca Lima
Tashima, Alexandre Keiji
Brunialti, Milena Karina Colo
Torquato, Ricardo Jose Soares
Bafi, Antonio
Assuncao, Murillo
Azevedo, Luciano Cesar Pontes
Salomao, Reinaldo
Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis
title Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis
title_full Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis
title_fullStr Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis
title_full_unstemmed Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis
title_short Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis
title_sort lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631513/
https://www.ncbi.nlm.nih.gov/pubmed/31341447
http://dx.doi.org/10.1186/s12014-019-9252-2
work_keys_str_mv AT sharmanarendrakumar lipidmetabolismimpairmentinpatientswithsepsissecondarytohospitalacquiredpneumoniaaproteomicanalysis
AT ferreirabiancalima lipidmetabolismimpairmentinpatientswithsepsissecondarytohospitalacquiredpneumoniaaproteomicanalysis
AT tashimaalexandrekeiji lipidmetabolismimpairmentinpatientswithsepsissecondarytohospitalacquiredpneumoniaaproteomicanalysis
AT brunialtimilenakarinacolo lipidmetabolismimpairmentinpatientswithsepsissecondarytohospitalacquiredpneumoniaaproteomicanalysis
AT torquatoricardojosesoares lipidmetabolismimpairmentinpatientswithsepsissecondarytohospitalacquiredpneumoniaaproteomicanalysis
AT bafiantonio lipidmetabolismimpairmentinpatientswithsepsissecondarytohospitalacquiredpneumoniaaproteomicanalysis
AT assuncaomurillo lipidmetabolismimpairmentinpatientswithsepsissecondarytohospitalacquiredpneumoniaaproteomicanalysis
AT azevedolucianocesarpontes lipidmetabolismimpairmentinpatientswithsepsissecondarytohospitalacquiredpneumoniaaproteomicanalysis
AT salomaoreinaldo lipidmetabolismimpairmentinpatientswithsepsissecondarytohospitalacquiredpneumoniaaproteomicanalysis